- Home
- SYRE vs BBN Comparison
SYRE vs BBN Comparison
Compare SYRE & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- BBN
- Stock Information
- Founded
- SYRE 2013
- BBN 1983
- Country
- SYRE United States
- BBN United States
- Employees
- SYRE N/A
- BBN N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- BBN Finance Companies
- Sector
- SYRE Health Care
- BBN Finance
- Exchange
- SYRE Nasdaq
- BBN Nasdaq
- Market Cap
- SYRE 1.1B
- BBN 1.0B
- IPO Year
- SYRE 2016
- BBN N/A
- Fundamental
- Price
- SYRE $15.86
- BBN $16.60
- Analyst Decision
- SYRE Buy
- BBN
- Analyst Count
- SYRE 5
- BBN 0
- Target Price
- SYRE $55.00
- BBN N/A
- AVG Volume (30 Days)
- SYRE 414.7K
- BBN 231.8K
- Earning Date
- SYRE 11-06-2025
- BBN 01-01-0001
- Dividend Yield
- SYRE N/A
- BBN 6.90%
- EPS Growth
- SYRE N/A
- BBN N/A
- EPS
- SYRE N/A
- BBN N/A
- Revenue
- SYRE N/A
- BBN N/A
- Revenue This Year
- SYRE N/A
- BBN N/A
- Revenue Next Year
- SYRE N/A
- BBN N/A
- P/E Ratio
- SYRE N/A
- BBN N/A
- Revenue Growth
- SYRE N/A
- BBN N/A
- 52 Week Low
- SYRE $10.91
- BBN $14.33
- 52 Week High
- SYRE $40.26
- BBN $18.36
- Technical
- Relative Strength Index (RSI)
- SYRE 42.99
- BBN 65.87
- Support Level
- SYRE $15.80
- BBN $16.48
- Resistance Level
- SYRE $17.58
- BBN $16.72
- Average True Range (ATR)
- SYRE 0.74
- BBN 0.12
- MACD
- SYRE -0.11
- BBN 0.02
- Stochastic Oscillator
- SYRE 9.78
- BBN 83.93
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.